Previous research has shown that PAR6 is involved in cancer initiation, progression and metastasis [41], and blocking the interaction between PAR6 and PKC1 could suppress the growth of lung tumor [42] and human lung cancer cells [43]. Here, PARD6A is linked to lung cancer.